[ad_1]
Reuters .- Billionaire Bill Gates and emeritus president of Estée Lauder, Leonard Lauder, announced Tuesday that they will allocate $ 30 million over a three-year period to support development new tests for early detection The launch of the Diagnostics Accelerator program follows the announcement last November of a personal investment of $ 50 million from Gates in the Dementia Discovery Fund, a private fund which aims to bring together industry and governments
The decision, said the co-founder of Microsoft, was motivated in part by his personal experience, since several members of his family are dealing with the disease. Alzheimer.
Alzheimer's, the most common form of Alzheimer's disease. Dementia affects approximately 50 million people worldwide and it is predicted that by 2050 it will suffer from more than 131 million people, according to Alzheimer's Disease International (ADI). 02] Gates and Lauder provided seed money for collaboration in diagnostics development through the Alzheimer's Drug Discovery Foundation (ADDF), created by Lauder. Other philanthropists will also collaborate, such as the Dolby family and the Charles and Helen Schwab Foundation.
Funds raised through this initiative will be open to scientists and doctors around the world who work in research centers, biotechnology companies and
ADDF Diagnostics Accelerator will invest in projects risks that may not have an immediate commercial impact, the group said in a statement.
Pharmaceuticals have invested billions of dollars in unsuccessful attempts to develop a treatment. which slows the progress of Alzheimer's disease, which strips people who are suffering from their memories and their ability to take care of themselves.
Source link
